An adaptive mesh redistribution method for nonlinear Hamilton--Jacobi equations in two-and three-dimensions

Huazhong Tang,T. Tang,Pingwen Zhang

DOI: https://doi.org/10.1016/S0021-9991(03)00192-X

2003-07-01

Abstract:

What problem does this paper attempt to address?

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Mi-Zu Jiang,Hirokazu Tsukahara,Kazuyo Hayakawa,Yukiko Todoroki,Satoshi Tamura,Yusei Ohshima,Masahiro Hiraoka,Mitsufumi Mayumi

DOI: https://doi.org/10.1016/j.rmed.2004.10.007

IF: 4.3

2005-01-01

Respiratory Medicine

Abstract:Pro-inflammatory cytokines initiate the vascular inflammatory response via upregulation of adhesion molecules on the endothelium. Recent observations suggest that reactive oxygen intermediates may play a pivotal role in TNF-α signaling and upregulate gene expression. We therefore evaluated the effects of pyrrolidine dithiocarbamate (PDTC; 0.1 mM) and spermine NONOate (Sper-NO; 1mM) on adhesion molecule expression and nuclear factor kappa B (NF-κB) activation induced by TNF-α(10ng/ml) in cultured human pulmonary microvascular endothelial cells (PMVEC). Treatment of cells with TNF-α for 4h significantly induced the surface expression of E-selectin and ICAM-1. Treatment with TNF-α for 8h significantly induced the surface expression of E-selectin, ICAM-1 and VCAM-1. The upregulation of these adhesion molecules was suppressed significantly by pretreatment with PDTC or Sper-NO for 1h. 8-Bromo-cyclic GMP (1mM) had no such effect, suggesting that the NO donor's effect was non-cGMP-dependent. The mRNA expression of E-selectin, ICAM-1 and VCAM-1, and activation of NF-κB induced by TNF-α for 2h were decreased significantly by the above two pretreatments. N-acetylcysteine (10mM) and S-nitroso-N-acetylpenicillamine (1mM) had little inhibitory effects on the cell surface and mRNA expression of these adhesion molecules stimulated by TNF-α. Treatment with TNF-α for 4h enhanced HL-60 leukocyte adhesion to human PMVEC, the effect of which was inhibited significantly by pretreatment with PDTC or Sper-NO. These findings indicate that both cell surface and mRNA expression of adhesion molecules in human PMVEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly in part through blocking the activation of NF-κB. Although our in vitro results cannot be directly extrapolated to the in vivo situation, they suggest a potential therapeutic approach for intervention in cytokine-mediated inflammatory processes in the human lung.
PDTC and NO Suppress CC Chemokine Production in TNF-α-stimulated Human Pulmonary Microvascular Endothelial Cells

Yoshio Mori,Hirokazu Tsukahara,Mi Zu Jiang,Mitsufumi Mayumi

DOI: https://doi.org/10.1016/j.rmed.2005.01.011

IF: 4.3

2005-01-01

Respiratory Medicine

Abstract:We recently reported in this journal that the expression of adhesion molecules, including E-selectin, ICAM-1 and VCAM-1, in human pulmonary microvascular endothelial cells (PMVEC) induced by TNF-α is inhibited significantly by pretreatment with pyrrolidine dithiocarbamate (PDTC) or spermine NONOate (Sper-NO), possibly in part through blocking the activation of NF-κB.1Jiang MZ, Tsukahara H, Hayakawa K, et al. Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med 2005, in press.Google Scholar As demonstrated by Blease et al. and others,2Blease K. Chen Y. Hellewell P.G. Burke-Gaffney A. Lipoteichoic acid inhibits lipopolysaccharide-induced adhesion molecule expression and IL-8 release in human lung microvascular endothelial cells.J Immunol. 1999; 163: 6139-6147PubMed Google Scholar, 3Murugesan G. Sandhya Rani M.R. Gerber C.E. et al.Lysophosphatidylcholine regulates human microvascular endothelial cell expression of chemokines.J Mol Cell Cardiol. 2003; 35: 1375-1384Abstract Full Text Full Text PDF PubMed Scopus (97) Google Scholar human PMVEC are capable of synthesizing chemokines such as IL-8, monocyte chemotactic protein (MCP)-1 and regulated upon activation, normal T-cell expressed and secreted (RANTES) upon a variety of pro-inflammatory stimuli. However, redox-regulated mechanisms of chemokine production in human PMVEC have never been elucidated. We therefore evaluated the impact of PDTC and Sper-NO on the production of CC chemokines induced by TNF-α in human PMVEC. Human PMVEC were cultured as described recently.1Jiang MZ, Tsukahara H, Hayakawa K, et al. Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med 2005, in press.Google Scholar Cell suspensions (5×104cells per well) were seeded on 24-well culture clusters. After cells reached confluence, human PMVEC were incubated for 8h in M199 medium alone or with 10ng/ml TNF-α in a final volume of 300μl. In other wells, cells were pretreated for 1h in M199 medium with 0.1mM PDTC or 1mM Sper-NO; they were then incubated in the same medium alone or with 10ng/ml TNF-α for 8h. Cell-free supernatants from resting or stimulated human PMVEC cultures were tested for MCP-1, RANTES (Biosource International, Inc., CA) and eotaxin (R&D Systems, Inc., MN) contents by sandwich ELISA kits according to the manufacturers’ protocols. Figure 1 shows that treatment of human PMVEC with TNF-α for 8h resulted in a significant increase in the production of MCP-1, RANTES and eotaxin, as compared to the non-stimulated cells. Of note, pretreatment for 1h with PDTC or Sper-NO significantly inhibited the production of MCP-1, RANTES and eotaxin induced by TNF-α. Chemokines are divided into the CXC, CC, C and CX3C subfamilies. Of these, CC chemokines are most diversified and act on monocytes, activated T-cells, eosinophils and basophils.4Cascieri M.A. Springer M.S. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention.Curr Opin Chem Biol. 2002; 4: 420-427Crossref Scopus (89) Google Scholar The NF-κB plays an important role in the gene regulation of chemokines, including MCP-1, RANTES and eotaxin. As shown in our recent paper, PDTC and Sper-NO inhibit NF-κB activation in human PMVEC.1Jiang MZ, Tsukahara H, Hayakawa K, et al. Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med 2005, in press.Google Scholar It was reported that PDTC inhibits the production of IL-8, MCP-1 and RANTES in human umbilical vein endothelial cells and pancreatic periacinar myofibroblasts through a blockade of NF-κB activation.5Munoz C. Pascual-Salcedo D. Castellanos M.C. et al.Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-κB and AP-1 transcription factors activity.Blood. 1996; 88: 3482-3490PubMed Google Scholar, 6Andoh A. Takaya H. Saotome T. et al.Cytokine regulation of chemokine (IL-8, MCP-1, and RANTES) gene expression in human pancreatic periacinar myofibroblasts.Gastroenterology. 2002; 119: 211-219Abstract Full Text Full Text PDF Scopus (145) Google Scholar NO suppresses the production of MCP-1 and RANTES in human umbilical vein endothelial cells and keratinocyte cell line HaCaT.7Zeiher A.M. Fisslthaler B. Schray-Utz B. Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells.Circ Res. 1995; 76: 980-986Crossref PubMed Scopus (371) Google Scholar, 8Wetzler C. Kampfer H. Pfeilschifter J. Frank S. Keratinocyte-derived chemotactic cytokines: expressional modulation by nitric oxide in vitro and during cutaneous wound repair in vivo.Biochem Biophys Res Commun. 2000; 274: 689-696Crossref PubMed Scopus (43) Google Scholar Our recent1Jiang MZ, Tsukahara H, Hayakawa K, et al. Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells. Respir Med 2005, in press.Google Scholar and present findings indicate that both adhesion molecule expression and chemokine production in human PMVEC induced by TNF-α are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-κB activation. These results suggest that restoration of the redox balance using antioxidants or NO may offer potential therapeutic approach in cytokine-mediated inflammatory reactions in the human lung.
Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

MZ Jiang,H Tsukahara,Y Ohshima,Y Todoroki,M Hiraoka,M Maeda,M Mayumi

DOI: https://doi.org/10.1016/j.lfs.2004.01.031

IF: 6.78

2004-01-01

Life Sciences

Abstract:Cell adhesion molecules expressed on endothelial cells in inflamed skin appear to be controlled by the actions of cytokines and reactive oxygen species. However, molecular mechanisms of the expression of adhesion molecules during skin inflammation are currently not well understood. To evaluate the role of antioxidants and nitric oxide in modulating inflammatory processes in the skin, we examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on adhesion molecule expression and nuclear factor kappa B (NF-KB) activation induced by TNF-alpha (10 ng/ml) in cultured human dermal microvascular endothelial cells (HDMEC). Treatment of cells with TNF-alpha for 4 h significantly induced the surface expression of E-selectin and intercellular adhesion molecule-1 (ICAM-1). Treatment with TNF-alpha for 8 h significantly induced the surface expression of E-selectin, ICAM-1 and vascular cell adhesion molecule-1 (VCAM-1). The up-regulation of these adhesion molecules was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h. The mRNA expression of E-selectin, ICAM-1 and VCAM-1, and activation of NF-kappaB induced by TNF-alpha for 2 h were significantly decreased by the above two pretreatments. N-acetylcysteine (10 mM) and S-nitroso-N-acetylpenicillamine (1 mM) had no significant inhibitory effects on the cell surface and mRNA expression of these adhesion molecules stimulated by TNF-. These findings indicate that both cell surface and mRNA expression of adhesion molecules in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly in part through blocking the activation of NF-KB. These results suggest a potential therapeutic approach using antioxidant agents or nitric oxide pathway modulators in the treatment of inflammatory skin diseases. (C) 2004 Elsevier Inc. All rights reserved.
Effects of Antioxidant and Nitric Oxide on Chemokine Production in Tnf-Alpha-Stimulated Human Dermal Microvascular Endothelial Cells

MZ Jiang,H Tsukahara,Y Ohshima,S Sato,Y Todoroki,M Hiraoka,M Mayumi

DOI: https://doi.org/10.1080/1071576042000209826

IF: 4.2878

2004-01-01

Free Radical Research

Abstract:Chemokines have been implicated convincingly in the driving of leukocyte emigration in different inflammatory reactions. Multiple signaling mechanisms are reported to be involved in intracellular activation of chemokine expression in vascular endothelial cells by various stimuli. Nevertheless, redox-regulated mechanisms of chemokine expression in human dermal microvascular endothelial cells (HDMEC) remain unclear. This study examined the effects of pyrrolidine dithiocarbamate (PDTC, 0.1 mM) and spermine NONOate (Sper-NO, 1 mM) on the secretion and gene expression of chemokines, interleukin (IL)-8, monocyte chemotactic protein (MCP)-1, regulated upon activation normal T cell expressed and secreted (RANTES), and eotaxin. This study also addresses PDTC and Sper-NO effects on activation of nuclear factor kappa B (NF-kappaB) induced by TNF-alpha (10 ng/ml). Treatment with TNF-alpha for 8 h significantly increased secretion of IL-8, MCP-1, and RANTES, but not of eotaxin, in cultured HDMEC. Up-regulation of these chemokines was suppressed significantly by pretreatment with PDTC or Sper-NO for 1 h, but not by 1 mM 8-bromo-cyclic GMP. The mRNA accumulation of IL-8, MCP-1, RANTES, and eotaxin, and activation of NF-kappaB were induced by TNF-alpha for 2 h; all were suppressed significantly by the above two pretreatments. These findings indicate that both secretion and mRNA accumulation of IL-8, MCP-1, and RANTES in HDMEC induced by TNF-alpha are inhibited significantly by pretreatment with PDTC or Sper-NO, possibly via blocking redox-regulated NF-kappaB activation. These results suggest that restoration of the redox balance using antioxidant agents or nitric oxide pathway modulators may offer new opportunities for therapeutic interventions in inflammatory skin diseases.
Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells.

R. Molday,D. Mackenzie

DOI: https://doi.org/10.1016/0022-1759(82)90007-2

1982-08-13

Abstract:
S‐Allyl‐L‐Cysteine Sulfoxide Inhibits Tumor Necrosis Factor‐Alpha Induced Monocyte Adhesion and Intercellular Cell Adhesion Molecule‐1 Expression in Human Umbilical Vein Endothelial Cells

Chai Hui,Wo Like,Fu Yan,Xie Tian,Wang Qiuyan,Huang Lifeng

DOI: https://doi.org/10.1002/ar.21070

2010-01-01

Abstract:Garlic and its water-soluble allyl sulfur-containing compound, S-Allyl-L-cysteine Sulfoxide (ACSO), have shown antioxidant and anti-inflammatory activities, inhibiting the development of atherosclerosis. However, little is known about the mechanism(s) underlying the therapeutic effect of ACSO in inhibiting the formation of atherosclerostic lesion. This study aimed to investigate whether ACSO could modulate tumor necrosis factor-alpha (TNF-alpha)-induced expression of intercellular cell adhesion molecule-1, monocyte adhesion and TNF-alpha-mediated signaling in human umbilical vein endothelial cells. While TNF-alpha promoted the intercellular cell adhesion molecule-1 mRNA transcription in a dose- and time-dependent manner, ACSO treatment significantly reduced the levels of TNF-alpha-induced intercellular cell adhesion molecule-1 mRNA transcripts (P < 0.01). Furthermore, ACSO dramatically inhibited TNF-alpha triggered adhesion of THP-1 monocytes to endothelial cells and porcine coronary artery rings. Moreover, ACSO mitigated TNF-alpha induced depolarization of mitochondrial membrane potential and overproduction of superoxide anion, associated with the inhibition of NOX4, a subunit of nicotinamide adenine dinucleotide phosphate-oxidase, mRNA transcription. In addition, ACSO also inhibited TNF-alpha-induced phosphorylation of JNK, ERK1/2 and IkappaB, but not p38. Apparently, ACSO inhibited proinflammatory cytokine-induced adhesion of monocytes to endothelial cells by inhibiting the mitogen-activated protein kinase signaling and related intercellular cell adhesion molecule-1 expression, maintaining mitochondrial membrane potential, and suppressing the overproduction of superoxide anion in endothelial cells. Therefore, our findings may provide new insights into ACSO on controlling TNF-alpha-mediated inflammation and vascular disease.
Effects of pentoxifylline on inflammatory response to acute lung injury induced by LPS in rats

Xia Xiaoping,Xu Futao,Zeng Yinming

DOI: https://doi.org/10.3969/j.issn.1004-5805.2006.12.018

2006-01-01

Abstract:Objective To investigate the effect of pentoxifylline(PTX) on cytokine expression of endotoxin-induced acute lung injury (ALI) in rats. Methods A rat model of ALI was established by intratracheal instillation of lipopolysaccaride (1.5mg/kg, 0.5ml) (LPS). Twenty-four male Sprague-Dawley rats were randomly divided into three groups with 8 rats each. The rats in group PTX, but not in group LPS, were given intravenously PTX 20mg/kg 40min before LPS injection. The rats in group C were injected with normal saline instead of LPS as in group LPS and PTX. At 7h after LPS, all rats were killed. The concentrations of tumor necrosis factor-α (TNF-α) and IL-10 in bronchoalveolar lavage fluid (BAL) were measured using enzyme-linked immunosorbent assay (ELISA). The ratio of lung wet to dry weight (W/D) and the concentration of albumin in BAL were measured as well.Results Compared with group LPS, the concentrations of TNF-α and albumin in BAL and the lung W/D ratio decreased significantly in the PTX group(P<0.05). And the concentration of IL-10 in the BAL of the PTX group increased significantly. Conclusion Pentoxifylline can protect the lung from ALI induced by endotoxin by attenuation inflammatory responses in rats.
Effects of Pentoxifylline on Nonalcoholic Fatty Liver Disease: a Meta-Analysis.

Juan Du,Yan-Yan Ma,Chao-Hui Yu,You-Ming Li

DOI: https://doi.org/10.3748/wjg.v20.i2.569

2014-01-01

Abstract:AIM: To evaluate the effects of pentoxifylline therapy in patients with nonalcoholic fatty liver disease (NAFLD).METHODS: We searched PubMed, Medline, Google Scholar, Embase, Web of Science, the Cochrane Library and the Chinese Biomedicine Database for all relevant controlled trials of pentoxifylline in patients with NAFLD from 1997 to July 2013. Five studies (3 randomized, double-blind, placebo-controlled trials and 2 prospective cohort studies with concurrent controls) were included in this meta-analysis. Statistical analysis was performed using RevMan 5.0 software.RESULTS: Five randomized trials of 147 patients with NAFLD/nonalcoholic steatohepatitis (NASH) were included. The results showed that compared to placebo, pentoxifylline therapy resulted in a significant decrease in body weight (P = 0.04), alanine aminotransferase (P < 0.00001), aspartate transaminase (P = 0.0006), glucose (P = 0.0008) and tumor necrosis factor-alpha (P = 0.007), but did not significantly affect body mass index (P = 0.28), total cholesterol (P = 0.80), triglyceride (P = 0.98), alkaline phosphatase (P = 0.29), gamma-glutamyl transferase (P = 0.39) and interleukin-6 (P = 0.38). With regard to histological changes, pentoxifylline only reduced the NAFLD activity score (P < 0.00001) and improved lobular inflammation (P < 0.0001). Improvements in steatosis grade (P = 0.11), ballooning (P = 0.10) and fibrosis (P = 0.50) were not obvious.CONCLUSION: Pentoxifylline therapy results in weight loss, improved liver function and histological changes in patients with NAFLD/NASH. Therefore, pentoxifylline may be a new treatment option for NAFLD. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
Immune response modulation by pentoxifylline in vitro

H Tilg,B Eibl,M Pichl,A Gächter,M Herold,J Brankova,C Huber,D Niederwieser

DOI: https://doi.org/10.1097/00007890-199307000-00036

Transplantation

Abstract:Pentoxifylline (PTX) has recently been shown to modulate TNF-alpha production and to reduce the incidence and severity of all major complications after BMT, including mucositis, veno-occlusive disease, renal insufficiency, hypertension, and graft-versus-host disease. To analyze in detail the effect of PTX on immune complications after BMT, we investigated the immunomodulatory effect of PTX on immune responses in vitro. The continuous presence of PTX significantly reduced the proliferative response of PBMC to PHA stimulation and to alloantigens in a dose-dependent manner. Starting at concentrations of 100 micrograms/ml, PTX was able to inhibit and, at 1000 micrograms/ml, completely block mitogen-induced proliferation. Maximal inhibition of more than 90% (91 +/- 4%) was also observed at PTX concentrations of 1000 micrograms/ml in the mixed lymphocyte culture (MLR) and by addition on day 0. However, lower but still significant suppression (13 +/- 7%) was achieved at concentrations of 10 micrograms/ml PTX. The inhibitory capacity of PTX was increased by mAbs against TNF-alpha (34 +/- 5% additional suppression at 100 micrograms/ml PTX) and not reversed by the addition of rTNF-alpha. The effect of PTX on the generation of CTLs in vitro was studied in the cell-mediated lymphotoxicity assay. PTX (100 micrograms/ml) significantly inhibited (P = 0.0178) the in vitro generation of CTLs when PTX was added to the culture on day 0. PTX also showed profound modulatory properties in the NK assay, with a reduction of 23 +/- 3% in specific lysis at 10 micrograms/ml PTX and maximal reductions of 88 +/- 3% at 1000 micrograms/ml PTX. Immunomodulatory properties of PTX were not only associated with blockage of TNF-alpha, as shown by decreased mRNA expression and TNF-alpha values in the culture supernatants, but also with an impaired production of other cytokines and secondary messages such as IFN-gamma and neopterin. PTX treatment, however, did not affect IFN-alpha or IL-1 beta production, and IL-6 release was even increased. PTX, therefore, has profound immunomodulatory properties in vitro, which are associated with selective inhibition of cytokine release and can be enhanced by the addition of mAbs against TNF-alpha, but not reversed by the addition of rTNF-alpha.
Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography

Mi Hyun Seo,Dae Won Kim,Yeon Sook Kim,Suk Keun Lee

DOI: https://doi.org/10.1371/journal.pone.0261797

IF: 3.7

2022-03-25

PLoS ONE

Abstract:Although pentoxifylline (PTX) was identified as a competitive non-selective phosphodiesterase inhibitor, its pharmacological effect has not been clearly elucidated. The present study explored the effect of low dose 10 μg/mL PTX (therapeutic dose) compared to high dose 300 μg/mL PTX (experimental dose) in RAW 264.7 cells through immunoprecipitation-based high performance liquid chromatography (IP-HPLC), immunohistochemistry, and western blot. 10 μg/mL PTX increased the expression of proliferation (Ki-67, PCNA, cyclin D2, cdc25A), epigenetic modification (KDM4D, PCAF, HMGB1), protein translation (DOHH, DHPS, eIF5A1), RAS signaling (KRAS, pAKT1/2/3, PI3K), NFkB signaling (NFkB, GADD45, p38), protection (HSP70, SOD1, GSTO1/2), survival (pAKT1/2/3, SP1, sirtuin 6), neuromuscular differentiation (NSEγ, myosin-1a, desmin), osteoblastic differentiation (BMP2, RUNX2, osterix), acute inflammation (TNFα, IL-1, CXCR4), innate immunity (β-defensin 1, lactoferrin, TLR-3, -4), cell-mediated immunity (CD4, CD8, CD80), while decreased the expression of ER stress (eIF2α, eIF2AK3, ATF6α), fibrosis (FGF2, CTGF, collagen 3A1), and chronic inflammation (CD68, MMP-2, -3, COX2) versus the untreated controls. The activation of proliferation by 10 μg/mL PTX was also supported by the increase of cMyc-MAX heterodimer and β-catenin-TCF1 complex in double IP-HPLC. 10 μg/mL PTX enhanced FAS-mediated apoptosis but diminished p53-mediated apoptosis, and downregulated many angiogenesis proteins (angiogenin, VEGF-A, and FLT4), but upregulated HIF1α, VEGFR2, and CMG2 reactively. Whereas, 300 μg/mL PTX consistently decreased proliferation, epigenetic modification, RAS and NFkB signaling, neuromuscular and osteoblastic differentiation, but increased apoptosis, ER stress, and fibrosis compared to 10 μg/mL PTX. These data suggest PTX has different biological effect on RWA 264.7 cells depending on the concentration of 10 μg/mL and 300 μg/mL PTX. The low dose 10 μg/mL PTX enhanced RAS/NFkB signaling, proliferation, differentiation, and inflammation, particularly, it stimulated neuromuscular and osteoblastic differentiation, innate immunity, and cell-mediated immunity, but attenuated ER stress, fibrosis, angiogenesis, and chronic inflammation, while the high dose 300 μg/mL PTX was found to alleviate the 10 μg/mL PTX-induced biological effects, resulted in the suppression of RAS/NFkB signaling, proliferation, neuromuscular and osteoblastic differentiation, and inflammation.

multidisciplinary sciences
Reducing the technical complexity and business risk of major systems projects

A. Thorogood,P. Yetton

DOI: https://doi.org/10.1109/HICSS.2004.1265608

2004-01-05

Abstract:Shared IT infrastructure achieves returns to scale and facilitates co-ordination. Determining the optimal investment is difficult because demand is derived from business projects that can "free-ride" once the infrastructure is established. Organisations control infrastructure investments by justifying them in business projects that are net present value (NPV) positive, such as business process re-engineering projects. This increases the technical complexity of the business project and misleadingly couples the project's business goals with shared infrastructure goals. Field research uncovered an alternative "deviant" model where a flexible, or agile, infrastructure is installed and justified ahead of the business needs. Those needs were then satisfied with multiple small business application projects, as each became NPV positive. The managers' intuition was that this gave them valuable options to capture benefits from uncertain future business scenarios. This paper draws on these insights to uncouple infrastructure projects from business projects while still aligning the two. Real options theory is applied both to control the costs and to specify the infrastructure flexibility. The assumption is that uncoupling would reduce technical complexity and lower business risk. The paper then shows how to improve business performance by using infrastructure flexibility either to suppress the cost variance of the IT projects or to amplify their business benefit variance, as called for by McGrath (1997) and Sambamurthy et al. (2003).
Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings.

Wen Tang,W. Chow,Ying Li,H. Kong,Yi-Wei Tang,B. Lemieux

DOI: https://doi.org/10.1086/650388

2010-04-15

Abstract:There is a clear need for an instrument-free molecular diagnostic system for detecting human immunodeficiency virus type 1 (HIV-1) RNA or DNA that can be used in developing countries. Such a test could be used for early diagnosis of HIV-1 infection during infancy and could serve as a surrogate end point for vaccine trials. We developed the IsoAmp HIV-1 assay (BioHelix Corporation), which targets the HIV-1 gag gene with use of isothermal reverse-transcription helicase-dependent amplification chemistry. The IsoAmp HIV assay uses a disposable amplicon containment device with an embedded vertical-flow DNA detection strip to detect the presence of HIV-1 amplicons. The vertical-flow DNA detection strip has a control line to validate the performance of the device and a test line to detect the analyte. The analyte is detected by a sandwich immunoassay for reporter moieties on a capture probe and a detection probe. The control line consists of the detection probe reporter moiety conjugated to the vertical-flow DNA detection strip. The preliminary limit of detection of the IsoAmp HIV assay was evaluated by testing serial dilutions of HIV-1 armored RNA (Assuragen). We found that 21 (75%) of 28 assays yielded positive results when 50 copies of HIV-1 armored RNA were input into the IsoAmp HIV reaction.
Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro

Simone S Schüller,Lukas Wisgrill,Elisabeth Herndl,Andreas Spittler,Elisabeth Förster-Waldl,Kambis Sadeghi,Boris W Kramer,Angelika Berger

DOI: https://doi.org/10.1038/pr.2017.41

Abstract:BackgroundPentoxifylline (PTX), a methylxanthine derivate with immunomodulating properties, has been used as adjunctive treatment in severe neonatal sepsis. The aim of the study was to investigate the anti-inflammatory effects of PTX on Lipopolysaccharides (LPS)-stimulated monocytes of preterm neonates in vitro compared with monocytes of term infants and adult controls.MethodsWhole cord blood samples and control adult blood samples were incubated with LPS and PTX. The expression of surface markers, phagocytosis, cytokine secretion, and Toll-like receptor (TLR)4 signaling of monocytes were assessed by flow cytometry. Changes of TLR4-messenger RNA (mRNA) levels were confirmed by reverse-transcriptase PCR.ResultsThe expression of CD14, CD11b, CD64, CD71, and CD80 was downregulated by PTX in a dose-dependent manner; the greatest effect was observed on CD14 and CD11b in preterm infants. PTX markedly downregulated LPS-induced tumor necrosis factor-α, interleukin (IL)-1β, and IL-6 levels in all age groups. Early IL-10 production was significantly downregulated by PTX in term and preterm neonates, while remaining unchanged in adults. Moreover, PTX downregulated TLR4 expression of monocytes on cellular and mRNA level, decreased signaling, and suppressed phagocytosis.ConclusionPTX downregulated TLR4 expression and signaling, thereby leading to strong anti-inflammatory properties in monocytes. Age-dependent differences were identified for CD14 and CD11b expression and IL-10 production.
Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis.

Wei Shi,Chengyun Xu,Musaddique Hussain,Fugen Wu,Meiping Lu,Xiling Wu,Lanfang Tang,Ximei Wu,Junsong Wu

DOI: https://doi.org/10.1097/shk.0000000000000863

2017-01-01

Abstract:Neutrophils are a population of inflammatory cells involved in acute lung injury (ALI), and lipopolysaccharide (LPS)-induced prolonged neutrophil survival and delayed neutrophil apoptosis hinder the alleviation of lung inflammation. Myosin light-chain kinase (MLCK) involved the RhoA/Rho kinase signaling pathway responsible for the cytoskeletal arrangement, and previous studies have revealed that inhibition of MLCK induces apoptosis in vitro and in vivo. In this study, glycogen-induced neutrophils isolated from rats or mice were incubated with ML-7, a MLCK-specific inhibitor, and LPS-induced ALI mice administrated with ML-7 were investigated, to demonstrate the roles of MLCK in neutrophil apoptosis as well as its possibility of contributing to the clearance of inflammation. We found that ML-7 dramatically promoted neutrophil apoptosis that possibly signal through the p38 to upregulate the expression of the apoptotic proteins caspase-9 and B-cell lymphoma 2 and to downregulate the expression of the antiapoptotic protein Bcl-2-associated X protein and myeloid cell leukemia-1. In mice, ML-7 accelerated the clearance of inflammation in LPS-induced ALI through attenuating neutrophil accumulation, histopathological changes, and pulmonary edema. ML-7 promoted elimination of inflammation possibly by accelerating neutrophil apoptosis and macrophage-mediated clearance. Moreover, ML-7 also reduced the LPS-induced production of proinflammatory cytokines interleukin-1β and tumor necrosis factor-α, and the activity of myeloperoxidase. Taken together, the present study uncovers a hitherto uncharacterized role of MLCK in neutrophil apoptosis that contributes to the alleviation of inflammation in response to LPS.
Super-resolution interpolation with a quasi blur-hypothesis

T. Saito,K. Ishikawa,T. Komatsu

DOI: https://doi.org/10.1109/ICIP.2011.6115631

2011-12-29

Abstract:We propose a new sparse-representation approach to super-resolution color-image interpolation. Whether an image to be interpolated actually undergoes blurs or not, the approach assumes that the image is blurred with a certain smoothing filter, and it first performs both deblurring and interpolation simultaneously so as to produce a provisional high-resolution image on the quasi blur-hypothesis, and then it blurs the provisional high-resolution image with the hypothesized blurring filter to produce a finally interpolated color-image. The quasi blur-hypothesis is introduced to enhance the spatially-regularization efficacy of the data-fidelity constraint in the variational problem of the super-resolution deblurring-and-interpolation. If a proper smoothing filter is chosen as the hypothesized blurring filter, the quasi blur-hypothesis approach can achieve state-of-the-art interpolation performance.
Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Lingjian Zhang,Yalei Zhao,Linxiao Fan,Kai Xu,Feiyang Ji,Zhongyang Xie,Xiaoxi Ouyang,Daxian Wu,Lanjuan Li

DOI: https://doi.org/10.1002/ptr.6299

IF: 6.388

2019-01-01

Phytotherapy Research

Abstract:Tectorigenin has received attention due to its antiproliferation, anti‐inflammatory, and antioxidant activities. In this study, we investigated the effects of tectorigenin on lipopolysaccharide (LPS)/D‐galactosamine(D‐GalN)‐induced fulminant hepatic failure (FHF) in mice and LPS‐stimulated macrophages (RAW 264.7 cells). Pretreatment with tectorigenin significantly reduced the serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), histological injury, apoptosis, and the mortality of FHF mice, by suppressing the production of inflammatory cytokines such as TNF‐α and IL‐6. Tectorigenin also suppressed the activation of the inflammatory response in LPS‐stimulated RAW 264.7 cells. Tectorigenin‐induced protection is mediated through its mitigation of TLR4 expression, inhibition of mitogen‐activated protein kinase (MAPK) and nuclear factor‐κB (NF‐κB) pathway activation, and promotion of autophagy in FHF mice and LPS‐stimulated RAW 264.7 cells. Therefore, tectorigenin has therapeutic potential for FHF in mice via the regulation of TLR4/MAPK and TLR4/NF‐κB pathways and autophagy.
Effect of pentoxifylline on endothelial dysfunction, oxidative stress and inflammatory markers in STEMI patients

Asmaa Saeed,Mohamed Moustafa Farouk,Nagwa Ali Sabri,Mohamed Ayman Saleh,Marwa Adel Ahmed

DOI: https://doi.org/10.2144/fsoa-2023-0266

2024-05-15

Abstract:Aim: ST-elevation myocardial infarction (STEMI) patients suffer higher mortality and adverse outcomes linked to endothelial dysfunction (ED). Methods: 43 patients were randomized to pentoxifylline (PTX) 400 mg thrice daily (n = 22) or placebo (n = 21). Soluble vascular cell adhesion molecule-1, malondialdehyde, interleukin-1 (IL-1), interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP) and tumor necrosis factor-α (TNF-α) were assessed at baseline and 2 months. Results: After 2 months, no significant difference was observed in markers' levels between the 2 groups. However, a within-group comparison revealed a statistically significant change in hs-CRP in the PTX group (10.057 (9.779-10.331) versus 9.721 (6.102-10.191)), p = 0.032. Conclusion: PTX for 2 months in STEMI patients was safe and well-tolerated but had no significant detectable effect on ED, oxidative stress or inflammatory markers. Clinical Trial Registration: NCT04367935 (ClinicalTrials.gov).
Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. In vitro and in vivo studies.

A Gilhar,N Grossman,S Kahanovicz,H Reuveni,S Cohen,A Eitan,A. Eitan

DOI: https://doi.org/10.2340/0001555576437441

1996-11-01

Abstract:Psoriasis is characterized by abnormal cell proliferation, inflammation and increased biosynthesis of various cytokines. The inhibitory effect of pentoxifylline on some cell functions has been reported widely. This property of pentoxifylline prompted an investigation of its possible role in controlling psoriasis. In the in vitro study normal human keratinocytes proliferation was determined and formation of cornified envelopes was assayed following treatment with pentoxifylline. The in vivo experiment consisted of nude mice grafted with psoriatic or normal skin treated with tetradecanyl phorbol 13 acetate. At the end of the treatment period, the grafts were excised and assessed for acanthosis and labelling index. The in vitro study showed that continuous exposure of normal human keratinocyte cultures to pentoxifylline resulted in a significant dose-dependent inhibition of proliferation, and in induction of cornified envelope formation. The in vivo experiments showed a significant reduction of epidermal thickness and of labeling index in psoriatic and tetradecanyl phorbol 13 acetate-treated normal skin, as compared to the initial values.

dermatology
Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells.

L. Gómez-Quiroz,L. Bucio,B. Farfan,M. C. Escobar,D. Kershenobich,M. Gutiérrez-Ruíz,E. Hernández,V. Souza

Cell Biology and Toxicology

Abstract:Overproduction of collagen (I) by activated hepatic stellate cells is a critical step in the development of liver fibrosis. It has been established that these cells express interleukin (IL)-6 and respond to this cytokine with an increase in alpha(I) collagen. Pentoxifylline, a methylxanthine derivate, has been reported to have antifibrotic properties, but the mechanism responsible for this effect is unknown. The aim of this study was to determine the effect of pentoxifylline on acetaldehyde-induced collagen production in a rat hepatic stellate cell line (CFSC-2G cells). Cells were treated with 100 microM acetaldehyde and 200 microM pentoxifyline for 3 h. IL-6 and alpha(I) collagen messenger RNA (mRNA) were determined by reverse transcriptase polymerase chain reaction (RT-PCR) assay. NFkappaB activation was determined by electrophoretic mobility shift assay. To corroborate NFkappaB participation in pentoxifylline effect, cells were pretreated with 10 microM TPCK, a NFkappaB inhibitor. IkappaBalpha was determined by Western blot. IL-6 expression decreased significantly in acetaldehyde-pentoxifylline-treated cells. Acetaldehyde-treated cells pretreated with an anti-IL-6 monoclonal antibody did not show any increase in alpha (I) collagen expression. Acetaldehyde-treated cells increased 1.48 times NFkappaB activation, whereas acetaldehyde-pentoxifylline-treated cells decreased NFkappaB activation to control values. TPCK pretreated acetaldehyde cells did not present NFkappaB activation. To corroborate NFkappaB participation in pentoxifylline effect, IkappaBalpha was determined. IkappaBalpha protein level decreased 50% in acetaldehyde-treated cells, while acetaldehyde-pentoxifylline-treated cells showed IkappaBalpha control cells value. The data suggest that acetaldehyde induced alpha(I) collagen and IL-6 expression via NFkappaB activation. Pentoxifylline prevents acetaldehyde-induced alpha(I) collagen and IL-6 expression by a mechanism dependent on IkappaBalpha degradation, which in turn blocks NFkappaB activation.

Medicine
A neuroprotective effect of pentoxifylline in rats with diabetic neuropathy: Mitigation of inflammatory and vascular alterations

Raghda A.M. Salama,Fatema Ahmed Raafat,Amany Helmy Hasanin,Nevien Hendawy,Lobna A. Saleh,Eman K. Habib,May Hamza,Ahmed Nour Eldin Hassan

DOI: https://doi.org/10.1016/j.intimp.2024.111533

IF: 5.714

2024-01-26

International Immunopharmacology

Abstract:Background Treatment of diabetic neuropathic pain does not change the natural history of neuropathy. Improved glycemic control is the recommended treatment in these cases, given that no specific treatment for the underlying nerve damage is available, so far. In the present study, the potential neuroprotective effect of pentoxifylline in streptozotocin (50 mg/kg) induced diabetic neuropathy in rats was investigated. Methods Pentoxifylline was administered at doses equivalent to 50, 100 & 200 mg/kg, in drinking water, starting one week after streptozotocin injection and for 7 weeks. Mechanical allodynia, body weight and blood glucose level were assessed weekly. Epidermal thickness of the footpad skin, and neuroinflammation and vascular alterations markers were assessed. Results Tactile allodynia was less in rats that received pentoxifylline at doses of 100 and 200 mg/kg (60 % mechanical threshold increased by 48 % and 60 %, respectively). The decrease in epidermal thickness of footpad skin was almost completely prevented by the same doses. This was associated with a decrease in spinal tumor necrosis factor alpha (TNFα) and nuclear factor kappa B levels and a decrease in microglial ionized calcium binding adaptor molecule 1 immunoreactivity, compared to the control diabetic group. In sciatic nerve, there was decrease in TNF-α and vascular endothelial growth factor levels and intercellular adhesion molecule immunoreactivity. Conclusion Pentoxifylline showed a neuroprotective effect in streptozotocin-induced diabetic neuropathy, which was associated with a suppression of both the inflammatory and vascular pathogenic pathways that was not associated with a hypoglycemic effect. Thus, it may represent a potential neuroprotective drug for diabetics.

pharmacology & pharmacy,immunology

An adaptive mesh redistribution method for nonlinear Hamilton--Jacobi equations in two-and three-dimensions

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

PDTC and NO Suppress CC Chemokine Production in TNF-α-stimulated Human Pulmonary Microvascular Endothelial Cells

Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

Effects of Antioxidant and Nitric Oxide on Chemokine Production in Tnf-Alpha-Stimulated Human Dermal Microvascular Endothelial Cells

Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells.

S‐Allyl‐L‐Cysteine Sulfoxide Inhibits Tumor Necrosis Factor‐Alpha Induced Monocyte Adhesion and Intercellular Cell Adhesion Molecule‐1 Expression in Human Umbilical Vein Endothelial Cells

Effects of pentoxifylline on inflammatory response to acute lung injury induced by LPS in rats

Effects of Pentoxifylline on Nonalcoholic Fatty Liver Disease: a Meta-Analysis.

Immune response modulation by pentoxifylline in vitro

Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography

Reducing the technical complexity and business risk of major systems projects

Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings.

Pentoxifylline modulates LPS-induced hyperinflammation in monocytes of preterm infants in vitro

Inhibition of Myosin Light-Chain Kinase Enhances the Clearance of Lipopolysaccharide-Induced Lung Inflammation Possibly by Accelerating Neutrophil Apoptosis.

Super-resolution interpolation with a quasi blur-hypothesis

Tectorigenin Protects Against Experimental Fulminant Hepatic Failure by Regulating the TLR4/mitogen‐activated Protein Kinase and TLR4/nuclear Factor‐κb Pathways and Autophagy

Effect of pentoxifylline on endothelial dysfunction, oxidative stress and inflammatory markers in STEMI patients

Antiproliferative effect of pentoxifylline on psoriatic and normal epidermis. In vitro and in vivo studies.

Pentoxifylline downregulates alpha (I) collagen expression by the inhibition of Ikappabalpha degradation in liver stellate cells.

A neuroprotective effect of pentoxifylline in rats with diabetic neuropathy: Mitigation of inflammatory and vascular alterations